ArticleJournal of clinical medicine2023

The Long-Term Benefit of Sacubitril/Valsartan in Patients with HFrEF: A 5-Year Follow-Up Study in a Real World Population.

Giuseppe Dattilo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.